Key Financial Data Of Group

JCR Pharmaceuticals Co.,Ltd. - Filing #7295903

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
Key financial data of group
Business results of group
Net sales
16,657,000,000 JPY
42,871,000,000 JPY
24,272,000,000 JPY
Ordinary profit (loss)
-1,621,000,000 JPY
7,264,000,000 JPY
7,126,000,000 JPY
Profit (loss) attributable to owners of parent
-691,000,000 JPY
5,507,000,000 JPY
5,253,000,000 JPY
Comprehensive income
1,788,000,000 JPY
6,475,000,000 JPY
5,877,000,000 JPY
Net assets
57,049,000,000 JPY
56,475,000,000 JPY
57,125,000,000 JPY
Total assets
104,622,000,000 JPY
102,226,000,000 JPY
103,988,000,000 JPY
Basic earnings (loss) per share
-5.53
44.13
42.10
Diluted earnings per share
43.92
41.90
Equity-to-asset ratio
0.541 xbrli:pure
0.542 xbrli:pure
0.539 xbrli:pure
Net cash provided by (used in) operating activities
-1,109,000,000 JPY
9,312,000,000 JPY
3,521,000,000 JPY
Net cash provided by (used in) investing activities
-2,962,000,000 JPY
-2,690,000,000 JPY
-1,288,000,000 JPY
Net cash provided by (used in) financing activities
3,852,000,000 JPY
-2,031,000,000 JPY
-761,000,000 JPY
Cash and cash equivalents
18,271,000,000 JPY
18,756,000,000 JPY
15,968,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.